abstract |
The present invention relates to heteroaryl substituted pyrrolo that modulates the activity of Janus kinase and is useful in the treatment of diseases associated with the activity of Janus kinase, such as immune related diseases, skin disorders, myeloproliferative disorders, cancer, and other diseases. [2,3-b] pyridine (I) and heteroaryl substituted pyrrolo [2,3-b] pyrimidines are provided. (I) |